School of Public Health faculty discuss benefits of COVID-19 vaccine approval for children
By ALICE ZHAO | November 17, 2021The pediatric COVID-19 vaccine for children from age 5 to 11 years old was approved by the Centers for Disease Control and Prevention (CDC) on Nov. 2 and has since been distributed in hospitals and pharmacies nationwide. The News-Letter interviewed School of Public Health faculty Dr. Kawsar Talaat and Tamar Mendelson to discuss the impact this will have on children's wellbeing.




















